When was FBLG stock made available for the first time to the public?

The IPO Date for FBLG is 2024-02-01. On this 2024-02-01, FBLG stock was made publicly available.

Where is the headquarters of FBLG stock?

Headquarters of FBLG is in US at 455 East Medical Center Boulevard, Houston, DE 77598.

What industry does FBLG belong to?

The FBLG belongs to Biotechnology.

FibroBiologics, Inc. Common Stock

FBLG•NASDAQ

Healthcare

Biotechnology

$0.70

$-0.02(-3.12%)

FibroBiologics, Inc. Common Stock (FBLG) Company Profile & Overview

Explore FibroBiologics, Inc. Common Stock’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

FibroBiologics, Inc. Common Stock (FBLG) Company Profile & Overview

FibroBiologics, Inc., a clinical-stage cell therapy company, develops and commercializes fibroblast-based therapies in the United States. It is developing CybroCell, for the treatment of degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for wound healing. The company is also on the early-stage research of CYTER915, which is designed to regenerate or reinvigorate production of the thymus and/or spleen; CYPS317, for the treatment of psoriasis; and TCB190 to treat certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.

SectorHealthcare

IndustryBiotechnology

CEOMr. Peter O'Heeron

Contact Information

https://www.fibrobiologics.com

281 651 5150

455 East Medical Center Boulevard, Houston, DE, 77598

Company Facts

13 Employees

IPO DateFeb 1, 2024

CountryUS

Actively Trading

Frequently Asked Questions

;